Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: A systematic review of methodology and reporting standards

Epilepsia

Volumn 41, Issue 11, 2000, Pages 1357-1363

  Baker, Gus A ^a   Hesdon, Bernadette ^a   Marson, Anthony G ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Behavioral outcomes; Clinical trials; Psychological; Systematic review

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLORAZEPATE; DEZINAMIDE; ETEROBARB; ETHOSUXIMIDE; FELBAMATE; FOLIC ACID; LAMOTRIGINE; LEVODOPA; LORAZEPAM; METHYLPHENIDATE; OXIRACETAM; PHENOBARBITAL; PHENYTOIN; SABELUZOLE; SULTIAME; TIAGABINE; TRYPTOPHAN; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; ANTICONVULSANT THERAPY; ARTICLE; BEHAVIOR; CHILD; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; EPILEPSY; EVALUATION; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; VALIDATION PROCESS;

ADULT; ANTICONVULSANTS; CHILD; DATABASES; EPILEPSY; HEALTH STATUS INDICATORS; HUMANS; MMPI; OUTCOME ASSESSMENT (HEALTH CARE); PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 0033761618     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00110.x     Document Type: Article

References (55)

1. Commission on Outcome Measurement in Epilepsy, 1994-1997: Final Report
2. Quality of life in epilepsy
3. Assessing quality of life in patients with epilepsy
4. Carbamazepine: Behavioral, anticonvulsant and EEG effects in chronically hospitalized epileptics
5. Psychometric study of children with learning problems and 14-6 positive spike EEG patterns treated with ethosuximide (Zarontin) and placebo
6. Short-term treatment with levetiracetam enhances health-related quality of life in patients with refractory epilepsy
7. Epilepsy Group Module
8. How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches
9. A systematic review of neuropsychological outcomes of randomized controlled trials of antiepileptic medication
10. Carbamazepine for epilepsy
11. Effects of sulthiame upon intellectual, neuropsychological, and social functioning abilities among adult epileptics: Comparison with diphenylhydantoin
12. Esterobarb therapy in epilepsy
13. Carbamazepine: A double-blind comparison with phenytoin
14. Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin
15. Clorazepate and phenobarbital as antiepileptic drugs: A double-blind study
16. Cinromide in epilepsy: A pilot study
17. Zonisamide in epilepsy: A pilot study
18. A randomized, double-blind, crossover study of phenobarbital and mephobarbital
19. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone
20. If a well-stabilized epileptic patient has a subtherapeutic antiepileptic drug level, should the dose be increased? A randomized prospective study
21. Comparative cognitive effects of anticonvulsants
22. Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine
23. Psychosocial outcomes of antiepileptic drug discontinuation
24. Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: A random trial
25. Impact of valproate and phenytoin on cognitive function in elderly patients: Results of a single-blind randomized comparative study
26. Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients
27. Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: A 2-year follow-up
28. Effect of valproate on cognitive functioning: Comparison with carbamazepine
29. A comparison of valproate with carbamazepine for the treatment of partial seizures and secondarily generalized tonic-clonic seizures in adults
30. Outcomes of add-on treatment with lamotrigine in partial epilepsy
31. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy
32. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures
33. Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy
34. Felbamate monotherapy has stimulant-like effects in patients with epilepsy
35. Stress and epilepsy: The value of a benzodiazepine (lorazepam)
36. Manipulation of cerebral monoamines in the treatment of human epilepsy: A pilot study
37. Folic acid in folate-deficient patients with epilepsy
38. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy
39. Neuropsychological effects of tiagabine, a potential new antiepileptic drug
40. Effects of sabeluzole (R58735) on memory functions in patients with epilepsy
41. Influence of vigabatrin on cognitive performances and behavior in patients with drug-resistant epilepsy
42. L-tryptophan in hyperactive child syndrome associated with epilepsy: A controlled study
43. Clobazam in therapy-resistant patients with partial epilepsy: A double-blind placebo-controlled crossover study
44. Dezinamide for partial seizures: Results of an n-of-1 design trial
45. Aspartame has no effect on seizures or epileptiform discharges in epileptic children
46. Gabapentin and cognition: A double-blind, dose-ranging, placebo-controlled study in refractory epilepsy
47. Psychologic and behavioral effects of antiepileptic drugs in children: A double-blind comparison between phenobarbital and valproic acid
48. Effects of vigabatrin on partial seizures and cognitive function
49. Methylphenidate in children with seizures and attention-deficit disorder
50. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects
51. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy
52. Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy
53. Folate therapy in epilepsy: A controlled study
54. Patient-validated content of epilepsy-specific quality of life measurement
55. Dodson E, Trimble MR